NCT06739330Recruiting
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
Source: ClinicalTrials.gov · Last updated 20 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the prevalence of thyroid dysfunction and its association with metabolic dysfunction-associated fatty liver disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 9 Dec 2024
- Start date
- 19 Dec 2024
- Primary completion date
- 1 May 2025
- Lead sponsor
- Tanta University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06739330
What you commit to
- Study type: Observational
- Planned participants: 150
- From 19 Dec 2024 to the primary completion date, 1 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of thyroid disease or treatment (e.g., thyroid nodules, thyroid cancer, hypothyroidism, and hyperthyroidism).
- Patients with alcoholic liver disease take more than 40g of alcohol (or four units) per day.
- Viral hepatitis.
Other
- Pregnant women.
Who the study is looking for
- Age ≥ 18 years.
- Both sexes.
- Patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tanta university Coordinator of this site? Confirm its status | Tanta | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.